Newsroom
All news stories
Latest news
Featured
S&P upgrades Hikma Pharmaceuticals PLC and its Senior Notes to ‘BBB’ on continued good business momentum; outlook stable
Press Release, Corporate
08 May 2025
- Hikma announces strong medium-term Group guidance ahead of its US site visit Press Release, Corporate 15 May 2025 Hikma announces strong medium-term Group guidance ahead of its US site visit
- Hikma announces settlement agreement for Xyrem® (sodium oxybate) U.S. class action lawsuits Press Release, Corporate 08 May 2025 Hikma announces settlement agreement for Xyrem® (sodium oxybate) U.S. class action lawsuits
- S&P upgrades Hikma Pharmaceuticals PLC and its Senior Notes to ‘BBB’ on continued good business momentum; outlook stable Press Release, Corporate 08 May 2025 S&P upgrades Hikma Pharmaceuticals PLC and its Senior Notes to ‘BBB’ on continued good business momentum; outlook stable
- Hikma reiterates full year guidance following good start to the year Press Release, Corporate 24 April 2025 Hikma reiterates full year guidance following good start to the year